News >

Abou-Alfa Highlights Pending Approvals, Sequencing Concerns, and Future Directions in HCC

Jessica Hergert
Published: Thursday, Apr 02, 2020

Ghassan K. Abou-Alfa, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center

Ghassan K. Abou-Alfa, MD

The armamentarium in advanced hepatocellular carcinoma (HCC) has undergone rapid expansion in recent years following a significant lull in drug development, said Ghassan K. Abou-Alfa, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication